Autoinjector
Latest Eli Lilly and Company Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
The broken lines of uneven length illustrate the boundary of the claimed design and form no part thereof. The broken lines of even length illustrate portions of the autoinjector and form no part of the claimed design.
Claims
The ornamental design for an autoinjector, as shown and described.
| D739011 | September 15, 2015 | Morrison, Jr. et al. |
| D773650 | December 6, 2016 | Fourt et al. |
| D851754 | June 18, 2019 | Boyaval et al. |
| D857192 | August 20, 2019 | Burkett et al. |
| D870270 | December 17, 2019 | Burkett et al. |
| D878560 | March 17, 2020 | Boyaval et al. |
| D882071 | April 21, 2020 | Stonecipher et al. |
| RE48006 | May 26, 2020 | Fourt et al. |
| D883475 | May 5, 2020 | Boyaval et al. |
| D893710 | August 18, 2020 | Neby |
| D898189 | October 6, 2020 | Boyaval et al. |
| D898900 | October 13, 2020 | Atterbury et al. |
| D926969 | August 3, 2021 | Dennisur et al. |
| D948039 | April 5, 2022 | Dastmalchi |
| D949706 | April 26, 2022 | Kim |
| RE49091 | June 7, 2022 | Fourt |
| D953885 | June 7, 2022 | Kim |
Type: Grant
Filed: Jun 3, 2022
Date of Patent: Oct 4, 2022
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Delroy George Dennisur (Smyrna, GA), Hemant Thakorbhai Patel (Indianapolis, IN), Amin Sedighiamiri (Carmel, IN), Parker Eugene Trow (Indianapolis, IN), Hsuan Tsun Wang (Atlanta, GA)
Primary Examiner: David G Muller
Application Number: 29/841,198